Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950157-25-000586·BIOGEN INC.
Schedule 13D ownership disclosure
N/A
Common Stock, par value $0.0001 per share · CUSIP: 78667J108
Event date: 2025-07-21
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Biogen Inc.Reported CIK 0000875045
Shares: 6,241,473 · Class: 10%
- Biogen MA Inc.
Shares: 6,241,473 · Class: 10%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950157-25-000586
- Form type
- SCHEDULE 13D/A
- Filer
- BIOGEN INC.
- CIK
- CIK 875045
- Filed
- Jul 21, 2025
- Reporting period
- Jul 21, 2025
- Description
- Schedule 13D beneficial ownership